C. Requejo
0000-0002-5440-5455
University of the Basque Country
7 papers found
Refreshing results…
Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers
6‐hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors
Topographical Distribution of Morphological Changes in a Partial Model of Parkinson’s Disease—Effects of Nanoencapsulated Neurotrophic Factors Administration
Angioglioneurinas y enriquecimiento ambiental: Una prometedora alianza para la restauración del cerebro
Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease
In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson’s disease
Missing publications? Search for publications with a matching author name.